BRCA1 and lung cancer: In addition, BRCA1-deficient breast cancer, non–small cell lung cancer, and colitis mouse models suggest that STING activation can repolarize immunosuppressive M2-like macrophages to the immune-activating M1-like phenotype (57–59).